» Articles » PMID: 24101872

A Peptide-mediated Targeting Gene Delivery System for Malignant Glioma Cells

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2013 Oct 9
PMID 24101872
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma multiforme (GBM) is the most common and malignant glioma. Although there has been considerable progress in treatment strategies, the prognosis of many patients with GBM remains poor. In this work, polyethylenimine (PEI) and the VTWTPQAWFQWV (VTW) peptide were modified and synthesized into GBM-targeting nanoparticles. The transfection efficiency of U-87 (human glioblastoma) cells was evaluated using fluorescence microscopy and flow cytometry. Cell internalization was investigated to verify the nanoparticle delivery into the cytoplasm. Results showed that the methods of polymer conjugation and the amount of VTW peptide were important factors to polymer synthesis and transfection. The PEI-VTW20 nanoparticles increased the transfection efficiency significantly. This report describes the use of VTW peptide-based PEI nanoparticles for intracellular gene delivery in a GBM cell-specific manner.

Citing Articles

Filamentous Bacteriophage-A Powerful Carrier for Glioma Therapy.

Wang Y, Sheng J, Chai J, Zhu C, Li X, Yang W Front Immunol. 2021; 12:729336.

PMID: 34566987 PMC: 8462735. DOI: 10.3389/fimmu.2021.729336.


A multi-functional nanoplatform for efficacy tumor theranostic applications.

Shi J, Zhang H, Chen Z, Xu L, Zhang Z Asian J Pharm Sci. 2020; 12(3):235-249.

PMID: 32104335 PMC: 7032091. DOI: 10.1016/j.ajps.2016.12.001.


Progress and perspectives on targeting nanoparticles for brain drug delivery.

Gao H Acta Pharm Sin B. 2016; 6(4):268-86.

PMID: 27471668 PMC: 4951594. DOI: 10.1016/j.apsb.2016.05.013.


Tumor-targeting peptides from combinatorial libraries.

Liu R, Li X, Xiao W, Lam K Adv Drug Deliv Rev. 2016; 110-111:13-37.

PMID: 27210583 PMC: 5856482. DOI: 10.1016/j.addr.2016.05.009.


A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.

Shi J, Wang B, Chen Z, Liu W, Pan J, Hou L Pharm Res. 2016; 33(6):1472-85.

PMID: 26984128 DOI: 10.1007/s11095-016-1891-7.


References
1.
Lungwitz U, Breunig M, Blunk T, Gopferich A . Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm. 2005; 60(2):247-66. DOI: 10.1016/j.ejpb.2004.11.011. View

2.
Frederiksen K, Abrahamsen N, Cristiano R, Damstrup L, Poulsen H . Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor. Cancer Gene Ther. 2000; 7(2):262-8. DOI: 10.1038/sj.cgt.7700098. View

3.
van Gaal E, van Eijk R, Oosting R, Kok R, Hennink W, Crommelin D . How to screen non-viral gene delivery systems in vitro?. J Control Release. 2011; 154(3):218-32. DOI: 10.1016/j.jconrel.2011.05.001. View

4.
Wu C, Lo S, Boulaire J, Hong M, Beh H, Leung D . A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro. J Control Release. 2008; 130(2):140-5. DOI: 10.1016/j.jconrel.2008.05.015. View

5.
Mathupala S, Guthikonda M, Sloan A . RNAi based approaches to the treatment of malignant glioma. Technol Cancer Res Treat. 2006; 5(3):261-9. DOI: 10.1177/153303460600500313. View